whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients

February 2011

Experts are debating whether a DOUBLE dose of clopidogrel (Plavix) prevents more cardiovascular events in stent patients.

Up to 25% of patients don't respond well to clopidogrel's antiplatelet effects...and are at higher risk for a cardiac event.

So some prescribers order platelet function tests to identify patients who have high platelet activity despite clopidogrel therapy.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote